<DOC>
	<DOCNO>NCT01117168</DOCNO>
	<brief_summary>Background : - The Children Oncology Group establish research network , Childhood Cancer Research Network ( CCRN ) , collect information child cancer condition benign involve abnormal cell growth order help doctor scientist well understand childhood cancer . The CCRN 's goal collect clinical information every child diagnose cancer similar condition United States Canada , allow researcher study pattern , characteristic , cause childhood cancer . The information also help researcher study cause childhood cancer . To expand CCRN , parent child diagnose cancer ask provide information child research purpose . Objectives : - To obtain informed consent parent ( child , appropriate ) infant , child , adolescent , young adult newly diagnose cancer enter name certain information concern child Childhood Cancer Research Network . - To obtain informed consent parent ( child , appropriate ) infant , child , adolescent , young adult newly diagnose cancer permission contact future consider participate non-therapeutic prevention research study involve parent and/or child . Eligibility : - Parents child see treated hospital member Children Oncology Group . Design : - Parents provide permission personal information send child hospital CCRN , include child parent ' name ; child 's gender , birth date , race , ethnicity ; information disease ; treat institution . - Parents also give permission CCRN contact diagnostic laboratory obtain specific information tumor cancer cell . - Parents ask willing contacted future consider participate CCRN research study , provide contact information ( name , home address , telephone number ) enter CCRN . - Parents patient change mind information available CCRN ask treatment institution restrict access identify information . Parents patient refuse information include CCRN contact future still able enter clinical cancer research study .</brief_summary>
	<brief_title>Enrollment Childhood Cancer Research Network ( CCRN ) Children Oncology Group</brief_title>
	<detailed_description>Background : - Institutional membership Children Oncology Group ( COG ) require registration pediatric cancer patient see site . This registration process include patient . - In order maximize resource network would provide , necessary identify information large proportion case include within network . Moreover , resource would enhance informed consent parents/patients obtain allow future contact regard possible participation non-therapeutic prevention research . Objectives : - To obtain informed consent parent infant , child , adolescent , young adult newly diagnose cancer ( child appropriate ) enter name certain information concern child Childhood Cancer Research Network and/or permission contact future consider participate future study . - For child age majority time parental consent : Once child reach age majority , obtain informed consent child allow her/his name identify information continue available Childhood Cancer Research Network and/or possibly contact future consider participate study . Eligibility : - Pre-CCRN Entry - All new patient see COG member institution follow diagnosis eligible : -- All cancer case ICD-O histologic behavior code two 2 ( carcinoma situ ) three 3 ( malignant ) . - -All lesion central nervous system regardless behavior , i.e. , benign , borderline malignant . - The benign/borderline condition reportable agreement shall include : Mesoblastic nephroma , teratoma , regardless location , Theca cell - granulosa cell tumor , lymphoproliferative disease , ganglioneuroma , myeloproliferative disease , Langerhan Cell histiocytosis Design : If consent enter patient ACCRN07 obtain : 1 . Using patient COG ID , CCRN consent add record patient consider registered COG . 2 . Depending response consent form , record flag yes possible contact future study CCRN . If consent obtain enter patient ACCRN07 1 . For parents/patients refuse CCRN consent , still able enrol COG clinical trial ( therapeutic non- therapeutic ) patient eligible . The unique COG ID use identify patient . 2 . The information collect part study entry procedure available CCRN . The record flag refuse participation CCRN . 3 . If consent later obtain enrollment CCRN , patient must enter ACCRN07 use patient unique COG ID .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : PreCCRN Entry All new patient see COG member institution follow diagnosis eligible : All cancer case ICDO histologic behavior code two 2 ( carcinoma situ ) three 3 ( malignant ) . All lesion central nervous system regardless behavior , i.e. , benign , borderline malignant . The benign/borderline condition reportable agreement shall include : Mesoblastic nephroma , teratoma , regardless location , Theca cell granulosa cell tumor , lymphoproliferative disease , ganglioneuroma , myeloproliferative disease , Langerhan Cell histiocytosis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 26, 2016</verification_date>
	<keyword>Children 's Oncology Group</keyword>
	<keyword>Pediatric Oncology</keyword>
	<keyword>Pediatric Cancer</keyword>
	<keyword>Registration</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Brain Tumor</keyword>
	<keyword>Sarcoma</keyword>
</DOC>